Pharma Industry News

Research calls for BRCA testing in all women

Written by David Miller

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at present, however, the standard method of screening for the genes is to invite women with a family history of either cancer for testing.

read more

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]